Stay updated on IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The site footer identifies the ClinicalTrials.gov interface as revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T03:01:59.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The study record history remains unchanged, showing its version timeline and the sections updated in prior submissions.
    Difference
    0.1%
    Check dated 2026-10-04T02:32:05.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The record history now contains a new revision label v3.7.0, replacing the previous v3.6.6 entry and updating the version history.
    Difference
    0.1%
    Check dated 2026-09-20T01:12:13.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    A new site revision tag 'Revision: v3.6.6' was added to the page, signaling a deployment of a newer version of the ClinicalTrials.gov interface and related updates to the record history view.
    Difference
    0.1%
    Check dated 2026-08-29T18:46:05.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The study history now includes a new 'Study Status' entry and an updated version count (15) in the Study Record Versions section, indicating the latest status and the addition of a new version in the record.
    Difference
    0.4%
    Check dated 2026-08-22T17:51:48.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Revision: v3.6.5 appears in the page footer, replacing v3.6.4, indicating a maintenance update to the ClinicalTrials.gov interface without changes to the study record.
    Difference
    0.1%
    Check dated 2026-08-08T09:15:39.000Z thumbnail image

Stay in the know with updates to IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page.